Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer
Clinical trial NCT02093962 · TERMINATED
Trial details
- NCT number
- NCT02093962
- Sponsor
- ImmunoGenesis
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2016-04-01
- Enrollment
- 265
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.